Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Tandem Diabetes Care (TNDM) Treasury Shares (2020 - 2025)

Tandem Diabetes Care (TNDM) has disclosed Treasury Shares for 5 consecutive years, with $151660.0 as the latest value for Q4 2024.

  • For the quarter ending Q4 2024, Treasury Shares rose 64.3% year-over-year to $151660.0, compared with a TTM value of $151660.0 through Dec 2024, up 64.3%, and an annual FY2024 reading of $151660.0, up 64.3% over the prior year.
  • Treasury Shares was $151660.0 for Q4 2024 at Tandem Diabetes Care, up from $92308.0 in the prior quarter.
  • Across five years, Treasury Shares topped out at $1.8 million in Q4 2022 and bottomed at $92308.0 in Q4 2023.
  • Average Treasury Shares over 5 years is $564266.6, with a median of $151660.0 recorded in 2024.
  • The sharpest move saw Treasury Shares surged 359.88% in 2021, then crashed 94.97% in 2023.
  • Year by year, Treasury Shares stood at $132802.0 in 2020, then soared by 359.88% to $610731.0 in 2021, then skyrocketed by 200.27% to $1.8 million in 2022, then plummeted by 94.97% to $92308.0 in 2023, then skyrocketed by 64.3% to $151660.0 in 2024.
  • Business Quant data shows Treasury Shares for TNDM at $151660.0 in Q4 2024, $92308.0 in Q4 2023, and $1.8 million in Q4 2022.